Skip to main content

Home/ CUPE Health Care/ Group items tagged europe

Rss Feed Group items tagged

Irene Jansen

Canada could take health-care lessons from Europe, Australia: study | News | National Post - 0 views

  • Canada should take some lessons from the largely overlooked health-care systems of Europe and Australia and shift to a “consumer-driven” culture that gives patients more choice in medical services, urges a novel new take on this country’s much-dissected medicare woes. In a white paper to be released Monday, researchers at the University of Western Ontario analyzed seven other industrialized countries and picked out ideas they say could help governments here fix spiralling health costs and chronic service shortcomings.
  • Anne Snowdon, head of the International Centre for Health Innovation at Western’s Ivey business school
  • The Ivey study did encompass the United States but focused more on six other countries: Britain, Germany, the Netherlands, France, Switzerland and Australia, most of which, it said, get better bang for the health-care buck than does Canada.
  • ...2 more annotations...
  • allow people to buy health insurance from a choice of up to 180 private insurers
  • Though there is a shortage of empirical evidence in any of the countries on what works, evidence suggests that such a system encourages patients and doctors to better manage their health, curbing the likelihood people will end up in an emergency ward or pricey acute-care hospital bed, the report said.
Heather Farrow

E-Rounds #50: Voluntary Private Health Insurance Among the Over 50s in Europe - 0 views

  • Voluntary Private Health Insurance Among the Over 50s in Europe Paccagnella, O, Vincenzo R, and Weber, G. Health Econ. 22(3) (2012):289-315. doi:10.1002/hec.2800. Epub 2012 Feb 7.
Govind Rao

Trade talks between US and EU could increase cost of drugs, new report says | BMJ - 0 views

  • BMJ 2014; 348 doi: http://dx.doi.org/10.1136/bmj.g2402 (Published 26 March 2014) Cite this as: BMJ 2014;348:g2402
  • Deborah Cohen
  • Ongoing free trade negotiations between the European Union and the United States will lead to agreements that will “limit transparency of clinical trials” and “increase the cost of medicines” if the drug industry has its way, a coalition of public health groups has said in a report.Whereas many trade negotiations focus mainly on tariffs, the Transatlantic Trade and Investment Partnership (TTIP) talks will set standards and legal frameworks for drug regulation, intellectual property rights, and investment protection, which the report says will “benefit [the] commercial interests of a few multinational firms.” The report has been produced by a coalition of groups including the International Society of Drug Bulletins, the Medicines in Europe Forum, Universities Allied for Essential Medicines Europe, Health Action International Europe, and the Commons Network. A spokeswoman for the European Federation of Pharmaceutical Industries and Associations defended the talks, telling …
CPAS RECHERCHE

TThe 'Make or Buy' Decision in Long-term Care: Lessons for Policy - 0 views

  •  
    Executive Summary This report was commissioned by the Swedish Ministr y of Health and Social Affairs with the aim of analysing the decision to make or to buy long-term care services, i.e. whether to deliver long-term care services through public providers or contract them out to public and non-public providers. This report reviews existing literature on the theoretic al underpinnings of the make or buy decision and how it applies to the specificities of long-term ca re. It analyses the implementation of quasi-markets in four European countries that represent different long-term care systems: England, Denmark, Germany and the Netherlands. It also critically rev iews six quality assessment and quality management systems in Europe and the issues surroun ding the definition and assessment of quality in long-term care.
Govind Rao

Health-care corruption: Patients bearing gifts | The Economist - 0 views

  • In central and eastern Europe, patients offer bribes and low-paid doctors accept them
  • Mar 24th 2015
Heather Farrow

The Dangers of Free Trade Agreements: TTIP's Threat to Europe's Elderly - 0 views

  • The most obvious approach to look at how European care for the elderly will evolve is to project technological trends and the costs of people living longer as diagnostic equipment, drug treatments and other medical science continues to improve. This kind of projection shows a rising cost to society of pensions and health care, because a rising proportion of the aging population is retiring. How will economies pay for it?
  • For starters, privatization is much more expensive than European-style Single Payer public health care. Monopoly prices also are higher. And of course, fraud is a problem.
Irene Jansen

CTV News Channel: Are cuts on the horizon? - 0 views

  •  
    Mike McBane: laying the ground for serious cuts, backing away from election promise of six percent for the duration of the accord, could translate to rural hospitals closing, we have a growing and aging population, we can't afford to cut without destabilizing services, need to stop tax cuts, Canada is not Europe re finances, need health care more than ever in times of economic insecurity (unemployment = poor health), if federal government cannot afford health care, who can?
Govind Rao

Rise of superbugs a global threat, WHO says - Europe - Al Jazeera English - 0 views

  • Increasing misuse of drugs has enabled the growth of drug-resistant superbugs which could give way to global epidemics.
  • 30 Apr 2014
  • The rise of superbugs and the misuse of antibiotics has enabled treatable diseases to once again become killers according to the World Health Organisation (WHO). A statement on Wednesday by the WHO comes as a United Nations study on antimicrobial resistance showed the problem was becoming a global emergency. In the first global report that gathered data from 114 countries the WHO said superbugs were able to evade event the hardest-hitting antibiotics.
Govind Rao

Globalization and Health | Full text | CETA and pharmaceuticals: impact of the trade ag... - 0 views

  • CETA and pharmaceuticals: impact of the trade agreement between Europe and Canada on the costs of prescription drugs Joel Lexchin123* and Marc-André Gagnon4
  • Globalization and Health 2014, 10:30  doi:10.1186/1744-8603-10-30
  • On a per capita basis, Canadian drug costs are already the second highest in the world after the United States and are among the fastest rising in the Organization for Economic Co-Operation and Development. The Comprehensive Economic and Trade Agreement (CETA) between the European Union (EU) and Canada will further exacerbate the rise in costs by: • Committing Canada to creating a new system of patent term restoration thereby delaying entry of generic medicines by up to two years; • Locking in Canada’s current term of data protection, and creating barriers for future governments wanting to reverse it; • Implementing a new right of appeal under the patent linkage system that will create further delays for the entry of generics.
Govind Rao

Economic platitudes not enough - Infomart - 0 views

  • Waterloo Region Record Thu Aug 27 2015
  • Canada's main political leaders have much to say about the ailing economy. None has yet produced a plausible plan to fix it. This week's stock market chaos served only to illustrate how ill-prepared the Conservatives, Liberals and New Democrats are when it comes to dealing with economic crisis. All responded with campaign bromides to the unsettling news that China, the world's No. 2 economy, is in trouble. Conservative Prime Minister Stephen Harper urged voters to stick with his recipe of tax cuts. Liberal Leader Justin Trudeau talked of the need to build the middle class.
  • New Democrat Leader Tom Mulcair, meanwhile, repeated his pledge to solve the crisis by lowering taxes for small business. These ideas aren't necessarily stupid. But in terms of dealing with an unusually stagnant economy, none of the parties' economic platforms - so far at least - is even remotely sufficient. First, look at where we are. The world economy has been weak since 2008. Europe and Japan are in trouble. The U.S. is only starting to pull out of its funk. For a while, China led the pack. But as this week's stock market scare demonstrated, China can be a slender reed to lean on. Former U.S. treasury secretary Larry Summers refers to what the world is going through now as "secular stagnation." It's as good a term as any.
  • ...4 more annotations...
  • In practical terms, it means the economy is creating jobs - but not good ones. It means that consumers are relying on credit cards rather than wages to buy what they need. It means that entire sectors of the economy are out of whack. In Canada, this expresses itself as a reliance on notoriously volatile commodities such as oil. When oil and other commodity prices are up, Canada does OK. When they fall, as is happening now, the reverse occurs. In his stump speech, Mulcair rightly criticizes the Harper Conservatives for failing to pay enough attention to manufacturing. He is also correct when he says that too many of the jobs created are low wage and part time. But his solution to date - give tax breaks to small business and manufacturers - is singularly inadequate. Small businesses, almost by definition, require low-wage, part-time, non-union workers. Encouraging small business may create jobs. But most will be of the precarious variety that Mulcair decries.
  • Tax breaks to manufacturers, meanwhile, may encourage them to expand production - but only if they have customers willing to buy. As Mulcair correctly points out, too many corporations are refusing to reinvest their profits. Logically, that means government should take up the slack - even if this leads to fiscal deficits in the short term. But Mulcair pledged Tuesday that an NDP government would not run deficits. Trudeau is less categorical. He says a Liberal government would balance the books over the long haul. But, wisely, he has not ruled out deficit spending in the short run. Trudeau's real problem is that his solution to the crisis is also insufficient.
  • He says his Liberals would take money from the very-well-to-do and give it to those earning between roughly $50,000 and $200,000. Trudeau refers to this as helping the middle class. Making the rich pay is not a bad idea - although the economy would get more of a boost if the poor, who spend most of what they earn, received the money instead. But how would Trudeau lessen Canada's reliance on oil? How would he protect us from the kinds of shocks that roiled the world this week? How would he promote manufacturing or high-wage, new-technology industries? So far, the Liberals haven't said.
  • Finally, the Conservatives. Harper's party does not fit the cartoon stereotypes. It hasn't embraced the harsh austerity favoured in Europe. Rather, the Harper government has followed a kind of austerity-light regimen. It has penalized the unemployed but left welfare and medicare alone (although the Conservatives have said they will cut health spending if re-elected). Both opposition parties criticize the Conservatives for having run deficits since 2008. But given the weakness of the economy, it was the right thing to do. Arguably, Harper's real sin on this front was to move too quickly to balance the books. Still, the prime minister has much to answer for. One example: His government used the temporary worker program to suppress wages, relenting only when the politics became impossible. But his biggest mistake was to rely on oil. When petroleum prices were high and China booming, this was sufficient to hide the economy's fatal flaws. Now it is not. Thomas Walkom's columns appear in Torstar newspapers.
Govind Rao

CETA: A win for Canada or European pharma? - 0 views

  • The day before the Canadian government hopes to clinch its Comprehensive Economic and Trade Agreement (CETA) with Europe at the Sept. 25 summit, opinion remains sharply divided on its cost implications for numerous medicines marketed by European pharmaceutical companies. CETA is the most ambitious trade deal ever between Canada and Europe, and pharmaceuticals are Europe’s most valuable category of exports to Canada.
Govind Rao

New Analysis Reexamines The Value Of Cancer Care In The United States Compared To Weste... - 0 views

  • doi: 10.1377/hlthaff.2014.0174 Health Aff March 2015 vol. 34 no. 3 390-397
  • Samir Soneji1,* and JaeWon Yang2
  • Our results suggest that cancer care in the United States may provide less value than corresponding cancer care in Western Europe for many leading cancers.
Irene Jansen

Private healthcare: the lessons from Sweden - 1 views

  • Over the past 15 years a coalition of liberals and conservatives has brought in for-profit free schools in education, has sliced welfare to pay off the deficit and has privatised large parts of the health service.
  • Sweden's private equity industry has grown into the largest in Europe relative to the size of its economy, with deals worth almost £3bn agreed last year. The key to this takeover was allowing private firms to enter the healthcare market
  • There are now six private hospitals funded by the taxpayer in Sweden, about 8% of the total.
  • ...8 more annotations...
  • In Britain the coalition has mimicked this approach. Circle, backed by private equity firms, runs Hinchingbrooke hospital in Cambridge.
  • Since 2010 private companies have had the right to set up large GP-style services
  • Corporates have set up 200 healthcare centres in two years, although critics point out that the majority have been in wealthier urban areas.
  • The Social Democrats, the main Swedish opposition party, have given up the idea of renationalising the health service and instead argue that profits should be capped and quality of care more tightly regulated.
  • more than 500 beds are being removed from the country's best known health centre, the Karolinska University hospital, and the services are being moved into the community to be run by private companies
  • a business-backed research institute, the Centre for Business and Policy Studies, looked at the privatisation of public services in Sweden and concluded that the policy had made no difference to the services' productivity. The academic author of the report, who stood by the findings, resigned after a public row.
  • Last year Stockholm county council, which controls healthcare for a fifth of the Swedish population, withdrew contracts from a private company after staff in a hospital were allegedly told to weigh elderly patients' incontinence pants to see if they were full or could be used for longer.
  • Swedish tax authorities are, however, taking some companies to court because pay in private equity groups is often linked to the profits made on deals and has been incorrectly taxed for years, it is said, at rates lower than that required for income in Sweden.
healthcare88

Time to revisit Canada Health Act - Infomart - 0 views

  • Waterloo Region Record Tue Nov 1 2016
  • We're paying some of the highest costs in the world for health care and we've got a middle-of-the-road health-care system." - Jane Philpott
  • On Oct. 18, the provincial health ministers met in Toronto and pushed for restoration of the previous six per cent annual increase in federal transfers in a renewed Health Accord. Federal Health Minister Jane Philpott refused, but promised extra funding targeted to home care, mental health and system innovation. But many provinces balked. As Quebec Health Minister Gaetan Barrette stated, "We are being asked to do more with less. All provinces and territories will have to make difficult choices."
  • ...11 more annotations...
  • Ontario Health Minister Eric Hoskins predicted that the reduction in the annual "escalator" to three per cent would result in a "declining partnership." Yet considering Ottawa contributes only 23 per cent of the average provincial health budget, the three per cent difference in the annual "escalator" translates into a reduced rate of increase of only 0.69 per cent! Much of this is mere political bluster! Is it not finally time to revisit the Canada Health Act and fine-tune it?
  • As Konrad Yakabuski has stated (Globe and Mail, Oct. 19), "As long as the provinces remain bound by the Canada Health Act, which constrains their ability to dramatically alter the way health care is paid for and delivered, any new conditions on the use of federal transfers are only likely to further weigh down an already overly bureaucratic system."
  • When it was passed in 1984, it was understood that the federal government would pay half of health costs. Now it covers less than a quarter. Thanks to Ottawa's admission of refugees and migrants, overall growth of an aging, sicker population, new diseases, and new technologies, the provinces must shoulder an increasing burden.
  • Yet as Bacchus Barua (Ottawa Sun, Oct. 21) has stressed, more efficient health care systems in Europe allow a greater role for the private sector, use co-payments and user fees (with exemptions for the poor and elderly) and fund hospitals according to activity, not by global budgets, which have been frozen in many provinces.
  • MDs could be required to work - perhaps 25 to 30 hours per week - in the public system in order to receive government reimbursement for malpractice insurance. Most MDs would confine their practice to the public system. They deserve fair treatment. Thus Philpott should amend the CHA to mandate binding arbitration when provincial negotiations fail.
  • For those not a member of a "special group," the main option for timely care may be to go to the United States. This provides employment to American doctors and nurses and profits to U.S. hospitals. Would it not make more sense to allow all Canadians to spend their after-tax discretionary income on their own health in their own province?
  • Frozen hospital global budgets have caused excessive wait times for knee and hip replacements as operating rooms are often not functioning at full capacity. According to a 2013 survey, 15 per cent of Canadian surgeons considered themselves underemployed and 64 per cent cited poor access to ORs. Hence if orthopedic surgeons had access to additional "private" OR time, wait times could be shortened. If hospitals were permitted to operate electively on Americans and other foreign patients, this would bring in extra revenue for hospitals and relieve the strain on provincial health ministries.
  • Philpott has vowed to do more than just "open the federal wallet." She admits that "innovation" is required. Yet governments are being constrained by blindly adhering to certain parts of the CHA. Despite denials by politicians, a "two-tier" system has always existed. Federal prisoners, WSIB patients, members of the military and RCMP, politicians and professional athletes usually obtain more timely care - often at private facilities.
  • When the premiers meet with Prime Minister Justin Trudeau in December, besides discussing funding of the new Health Accord, they need to revisit the CHA and begin putting forth proposals as to how best to amend and modernize it. Where wait times are excessive, certain diagnostic services and surgical procedures should allow for private access for all Canadians - not just a select few.
  • This would utilize expensive equipment and provide new employment for nurses, technicians and surgeons. It would provide extra revenue - from both inside and outside the country - that would help to keep universal public health care sustainable and accessible for all Canadians. Ottawa should then enforce all sections of the CHA on all provinces and territories.
  • Ottawa physician Dr. Charles Shaver was born in Montreal. He graduated from Princeton University and Johns Hopkins School of Medicine. He is currently chair of the section on general internal medicine of the Ontario Medical Association.
healthcare88

Why are we paying so much more for drugs than Europe? - The Hill Times - The Hill Times - 0 views

  • Monday, Oct. 17, 2016
  • A considerable amount of prescriptions, in many cases generously prescribed by some doctors, are wasted by patients. Furthermore, the belief that more prescriptions equals better health is wrong.
  • A considerable amount of prescriptions, in many cases generously prescribed by some doctors, are wasted by patients. Furthermore, the belief that more prescriptions equals better health is wrong.
  • ...4 more annotations...
  • By ANGELO PERSICHILLI
  • Monday, Oct. 17, 2016
  • TORONTO—A few weeks ago, Canadian consumers rejoiced because the cost of prescription drugs in Canada were lower than in the United States. But do they know that the cost of drugs in Canada is much higher than in most of the European countries?Laureano Leone, born in Italy, with a degree in pharmacy from the U.S., an Order of Canada, and experience as a former Ontario Liberal MPP, says that “it is unbelievable how our governments waste billions of dollars paying high prices for pharmaceuticals at the time when they close hospitals.”
  • Leone says that his findings have been validated by a renowned professor of York University, Joel Lexchin, and they “show that we are losing millions of dollars every day. Still there is refusal in recognition by the political establishment.”
Heather Farrow

Canadian health care: The elephant in the (waiting) room - The Rebel - 0 views

  • May 21, 2016
  • Bryan KapitzaRebel Blogger
  • For some incomprehensible reason, Canadians are unwilling to have a serious discussion about health care reform.Health care is the largest combined expenditure of our provincial and federal governments. Compared to other nations, Canadian health services have the longest wait times, are among the costliest, and least efficient and effective of developed nations. And still, despite all this evidence, there are powerful ideological groups that insist Canada has the best health care the world and any change would precipitate some sort of catastrophic social calamity.
  • ...1 more annotation...
  • Russia has a universal health care system, but it is by no means superior to that of the United States. Universality does not make our health care system better, just different.
Heather Farrow

Bayer and Monsanto: a Marriage Made in Hell - 0 views

  • May 27, 2016
  • by Martha Rosenberg – Ronnie Cummins
  • If Monsanto, perhaps the most hated GMO company in the world, joins hands with Bayer, one of the most hated Big Pharma corporations on Earth (whose evil deeds date back to World War I and the Nazi era), the newly formed seed-pesticide-drug behemoth would have combined annual sales of $67 billion.
  • ...15 more annotations...
  • In the 1980s, Bayer sold Factor VIII concentrate, a blood-clotting medicine acquired from Cutter Laboratories in 1978. Though Factor VIII carried a high risk of transmitting AIDS and Bayer knew, Bayer continued to sell the drug in Asia and Latin America while selling a new, safer product in the West.
  • takeover would dilute Bayer’s core drug business currently flush with sales of its blood-thinner Xarelto and Eylea, a drug to treat blindness.
  • Coalition Against Bayer Dangers
  • Bayer, a history of unsafe drugs
  • Monsanto’s first entry into Big Pharma.
  • Blood clotting drug spread AIDS
  • all three proposed mergers face antitrust reviews by agencies in the U.S., Europe and China,
  • In Hong Kong and Taiwan alone, more than 100 hemophiliacs got H.I.V. and “many have since died,” reported the New York Times. 
  • Statin Baycol recalled
  • In 2001, Bayer withdrew its lucrative new statin drug Baycol because more than 50 people had died and more than six million patients were at risk from the deadly side effects of rapidly dissolving of muscle tissue.
  • Yaz birth control pill causes deaths
  • Xarelto, shady approval of a dangerous drug
  • underreported bright side: Industries that are doing well generally spin off; industries that are performing poorly generally merge and consolidate.
  • Millions Against Monsanto movement,
  • Not a chance, On October 14-16, merged or not with Bayer, the OCA and the global grassroots will expose Monsanto’s crimes against humanity and the environment at the Monsanto Tribunal, a citizens’ tribunal which will take place in The Hague, Netherlands.
1 - 20 of 72 Next › Last »
Showing 20 items per page